Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
US Army
Julphar
Merck
Federal Trade Commission

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 7,999,148

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,999,148
Title:Cotton plant with seed-specific reduction in gossypol
Abstract: A method is disclosed for reducing the level of gossypol in cottonseed. The method generally includes selectively inducing RNA gene silencing in the seed of a transgenic cotton plant, to interfere with expression of the .delta.-cadinene synthase gene or the .delta.-cadinene-8-hydroxylase gene in the seed of the cotton plant without substantially affecting expression of that gene in the foliage, floral parts, and roots of the plant. The transgenic cotton plant comprises at least one of a .delta.-cadinene synthase gene trigger sequence and/or a .delta.-cadinene-8-hydroxylase gene trigger sequence operably linked to one or more a seed-specific promoter gene sequences, and the trigger sequence(s) is/are able to induce RNA gene silencing when expressed in cottonseed of the plant. Also disclosed are expression cassettes, vectors, cells, seeds, and plants containing at least one of a .delta.-cadinene synthase gene trigger sequence and/or a .delta.-cadinene-8-hydroxylase gene trigger sequence operably linked to one or more a seed-specific promoter DNA sequences.
Inventor(s): Rathore; Keerti S. (College Station, TX), Sunilkumar; Ganesan (College Station, TX), Campbell; LeAnne M. (Cypress, TX)
Assignee: Texas A&M University System (College Station, TX)
Application Number:11/707,760
Patent Claims:see list of patent claims

Details for Patent 7,999,148

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Texas A&M University System (College Station, TX) 2026-02-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Texas A&M University System (College Station, TX) 2026-02-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Texas A&M University System (College Station, TX) 2026-02-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,999,148

Country Patent Number Publication Date
United States of America 2007199098 Aug 23, 2007
United States of America 2011314572 Dec 22, 2011
United States of America 2015232869 Aug 20, 2015
United States of America 8987554 Mar 24, 2015
World Intellectual Property Organization (WIPO) 2007098001 Aug 30, 2007
World Intellectual Property Organization (WIPO) 2007098001 May 29, 2008
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Cantor Fitzgerald
QuintilesIMS
Accenture
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.